Vaxcyte (PCVX)
(Delayed Data from NSDQ)
$74.57 USD
-0.88 (-1.17%)
Updated May 17, 2024 04:00 PM ET
After-Market: $74.62 +0.05 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-1.00 | 0.00% |
Earnings Summary
For their last quarter, Vaxcyte (PCVX) reported earnings of -$0.85 per share, beating the Zacks Consensus Estimate of $-1.11 per share. This reflects a positive earnings surprise of 23.42%. Look out for PCVX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$1.00 per share, reflecting a year-over-year decrease of 42.86%.
Earnings History
Price & Consensus
Zacks News for PCVX
The Zacks Analyst Blog Highlights HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte
PCVX: What are Zacks experts saying now?
Zacks Private Portfolio Services